• PLEVA should be considered in children who present with coexisting papules, ulcers, and eschars. These skin lesions heal, leaving a hypopigmented scar. • Most children who have PLEVA are nontoxic in appearance and are healthy otherwise. • If systemic symptoms are prominent, FUMHD should be considered. • A skin biopsy is mandatory to confirm the diagnosis and exclude more serious conditions, such as malignancy or vasculitis. • Erythromycin is the medication most commonly used as first-line therapy. • Most PLEVA cases are self-limited, although some cases can have a relapsing course before resolving.
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health